Testing effectiveness (Phase 2)UnknownNCT00003257What this trial is testingGene Therapy in Treating Patients With Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Aventis Pharmaceuticals 39
Testing effectiveness (Phase 2)Looking for participantsNCT07115043What this trial is testingInvestigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more AstraZeneca 120
Early research (Phase 1)Study completedNCT00011778What this trial is testingPS-341 and Radiation to Treat Advanced Cancer of the Head and NeckWho this might be right forSquamous Cell Carcinoma National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT00021424What this trial is testingVaccine Therapy in Treating Patients With Stage IV Head and Neck CancerWho this might be right forHead and Neck CancerMetastatic Cancer National Institute on Deafness and Other Communication Disorders (NIDCD)
Large-scale testing (Phase 3)Study completedNCT00004917What this trial is testingRadiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck CancerWho this might be right forAnemiaHead and Neck Cancer Radiation Therapy Oncology Group
Very early researchWithdrawnNCT01967927What this trial is testingUnderstanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor TherapyWho this might be right forSquamous Cell Carcinoma of the Head and Neck University of Arkansas
Testing effectiveness (Phase 2)UnknownNCT00251381What this trial is testingCetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.Who this might be right forOropharyngeal Neoplasms Trial Form Support S.L. 90
Large-scale testing (Phase 3)Study completedNCT00273546What this trial is testingInduction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck CancerWho this might be right forCancer Sanofi 500
Testing effectiveness (Phase 2)Looking for participantsNCT06923761What this trial is testingEMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)Who this might be right forAdvanced Solid Malignancy Grey Wolf Therapeutics 300
Early research (Phase 1)Ended earlyNCT03854227What this trial is testingA Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Solid Tumors Pfizer 54
Not applicableWithdrawnNCT03611205What this trial is testingInterim Digital PET/CT in Predicting Outcomes for Participants With Locally Advanced Oropharyngeal Cancer Undergoing Chemoradiation TherapyWho this might be right forOropharyngeal Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma Ohio State University Comprehensive Cancer Center
Not applicableStudy completedNCT00184860What this trial is testingThe Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer PatientsWho this might be right forHead and Neck Neoplasms Radboud University Medical Center 80
Not applicableWithdrawnNCT04140513What this trial is testingDigital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal CancerWho this might be right forClinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Advanced Oropharyngeal Squamous Cell Carcinoma+5 more Ohio State University Comprehensive Cancer Center
Not applicableStudy completedNCT00628368What this trial is testingBiological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal CancerWho this might be right forColorectal CancerEsophageal Cancer Institut du Cancer de Montpellier - Val d'Aurelle 160
Testing effectiveness (Phase 2)Study completedNCT03719690What this trial is testingSafety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to TherapyWho this might be right forHRAS Gene MutationHNSCC Kura Oncology, Inc. 296
Testing effectiveness (Phase 2)Ended earlyNCT02042885What this trial is testingA Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced CancerWho this might be right forProstate CancerSalivary Gland CancerEndometrial Cancer+3 more Otsuka Novel Products GmbH 79
Large-scale testing (Phase 3)Ended earlyNCT00360971What this trial is testingPalifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck CancerWho this might be right forHead and Neck CancerMucositisPain+1 more Radiation Therapy Oncology Group 21
Testing effectiveness (Phase 2)UnknownNCT04999800What this trial is testingStudy of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1Who this might be right forHead and Neck Squamous Cell Carcinoma Shi Yuankai 20
Not applicableUnknownNCT01079546What this trial is testingHuman Papillomavirus (HPV) in Squamous Cell Carcinoma of the Head and NeckWho this might be right forEpidemiology Tel-Aviv Sourasky Medical Center 100
Not applicableActive Not RecruitingNCT05951127What this trial is testingAdditional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCCWho this might be right forEsophageal Squamous Cell CarcinomaOligometastatic Disease Cancer Institute and Hospital, Chinese Academy of Medical Sciences 141